A study by Norwegian and French researchers hopes to provide new understanding of how blood cells adjust gene expression in response to various clinical, biochemical and pathological conditions. The Norwegian Woman and Cancer (NOWAC) postgenome study, published March 12 in the open-access journal PLoS Genetics, highlights numerous blood gene sets affected by one's physical condition, lifestyle factors and exposure variables.
The authors used 286 blood samples from postmenopausal Norwegian women, collected from the NOWAC postgenome biobank and processed via both a standardized blood collection procedure and an experimentally-validated microarray platform. Using these samples, the researchers investigated blood gene expression changes due to technical variability (e.g., how samples were collected, transported, and stored), normal inter-individuality (e.g., body mass index), and exposure variables (e.g., smoking, hormone therapy, and medication use), at levels relevant to real life situations. They established that these effects are mirrored in the blood.
Although blood gene expression profiling promises molecular-level insight into disease mechanisms, there remains a lack of baseline data describing the nature and extent of variability in blood gene expression in the general population. Characterizations of this variation and the underlying factors that most influence gene expression among healthy individuals play an important role in the feasibility, design and analysis of future blood-based studies investigating biomarkers for exposure, disease progression, diagnosis or prognosis.
The authors conclude that their findings establish the feasibility of blood gene expression profiling to detect exposure-specific differences in the general population, and that failure to consider this type of technical or biological variation can result in the misidentification of genes when investigating predictive, diagnostic or prognostic signatures in blood.
FINANCIAL DISCLOSURE: This work was supported by grants from the Norwegian Research Council and the University of Tromsø. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
COMPETING INTERESTS: The authors have declared that no competing interests exist.
CITATION: Dumeaux V, Olsen KS, Nuel G, Paulssen RH, Børresen-Dale A-L, et al. (2010) Deciphering Normal Blood Gene Expression Variation--The NOWAC Postgenome Study. PLoS Genet 6(3): e1000873. doi:10.1371/journal.pgen.1000873
IN YOUR COVERAGE, PLEASE USE THIS LINK TO PROVIDE ACCESS TO THE FREELY AVAILABLE ARTICLE (the link will go live when the embargo ends): http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1000873
Institute of Community Medicine
University of Tromsø, Norway
This press release refers to an upcoming article in PLoS Genetics. The release is provided by the article authors and their institutions. Any opinions expressed in this release or article are the personal views of the journal staff and/or article contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the releases and articles and your use of such information.
About PLoS Genetics
PLoS Genetics (http://www.plosgenetics.org) reflects the full breadth and interdisciplinary nature of genetics and genomics research by publishing outstanding original contributions in all areas of biology.
About the Public Library of Science
The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.